(NASDAQ:JSPR), SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) — Company: Jasper, a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (“CSU”), Chronic Inducible Urticaria (“CIndU”), and Asthma. Class Period: November 30, 2023 – July 3, 2025 The Case: Robbins LLP reminds stockholders that a class action […]

JSPR Investors Should Contact Robbins LLP Regarding the Upcoming Lead Plaintiff Deadline in the Jasper Therapeutics, Inc. Class Action GlobeNewswire October 23, 2025 SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) — Company: Jasper, a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (“CSU”), Chronic Inducible Urticaria

Pioneering Startup Pivots from Fusion Propulsion to Accelerate Commercial Fusion with Compact NBI Technology Eos Atomics, formerly known as AeroFuse, today announced its strategic rebranding and the launch of its breakthrough Neutral Beam Injection (NBI) technology. This pivot positions the company to address the rapidly growing commercial fusion energy sector's critical need for compact, cost-effective

NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=173519&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) (“Ecopetrol” or the “Company”) announces that, The Chief Executive Officer of Ecopetrol S.A. (“Ecopetrol”) hereby summons all Shareholders to the extraordinary Assembly of the General Shareholders' Meeting to be held on Tuesday, November 11th, 2025, starting at 8:00 a.m., at the Auditorium of the Centro Internacional de Negocios y

Advancing Combinatorial Anti-Aging Therapies SINGAPORE, SG / ACCESS Newswire / October 22, 2025 / Immortal Dragons, a $40 million longevity fund, announced its strategic investment in Unlimited Bio, a biotechnology company developing combinatorial therapies to address the multi-system nature of aging. Combinatorial Therapeutic Strategy Unlimited Bio’s platform integrates gene therapies, biologics, plasma-based interventions, cell therapies,

Philadelphia, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) — The Option Sellers School (OSS), founded by seasoned options trader and educator Peter Pru, has just launched and it's quickly gaining traction among everyday investors seeking a simpler, more transparent path to income generation. The platform's flagship curriculum, the Ark Options Strategy, draws on more than a

NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=173518&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Peter Pru Launches Option Sellers School and the Ark Options Strategy to Redefine Options Education for Everyday Investors A transparent, education-first approach helping busy professionals generate consistent income without day trading. GlobeNewswire October 23, 2025 Philadelphia, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) — The Option Sellers School (OSS), founded by seasoned options trader and educator

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD) (OTCQB: DVHGF), a biopharmaceutical corporation specializing in the development of prescription drugs targeting inflammatory diseases today announced that Dr. André Boulet, PhD, Chairman and Chief Executive Officer, will present at